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An enigmatic yet fundamental principle of signal
transduction is that parallel signaling pathways
assembled from a common repertoire of enzymes
are able to propagate diverse physiological
responses. A key feature of such a mechanism is
that separate signaling pathways are organized into
localized transduction units, each tailored to
respond optimally to a particular signal.
Protein–protein interactions maintained by anchor-
ing, adapter and scaffolding proteins provide the
molecular glue that holds these signal transduction
units together. A major objective of the signaling
community is to ascertain how signals flow through
compartmentalized transduction units that contain
transmembrane receptors, protein kinases, phos-
phatases and their substrates. 
Introduction
Recent advances in our understanding of cell signal-
ing have highlighted the complexity of biological infor-
mation processing. While many components of these
signaling cascades are well known, it is still unclear
how multiple signaling pathways interact with each
other and how this communication is regulated.
Increasingly, attention is shifting towards understand-
ing the subcellular organization of signaling enzymes.
In this review, we will discuss the emergence of
‘signal-directing’ molecules that target the activity of
broad specificity protein kinases and phosphoprotein
phosphatases to predetermined cellular microenvi-
ronments. We will also discuss the use of kinase scaf-
folds in the segregation of parallel signal transduction
pathways that emanate from G-protein coupled
receptors. Finally, we will consider the implications of
these findings for future research directions that may
further elucidate the cellular role of these signaling
complexes. 
Signaling Networks and Compartmentalization
A cellular response to hormone action or growth factor
stimulation is often the engagement of signaling
complexes that include modulatory proteins, signaling
enzymes and their substrates. The integrity of these
multienzyme complexes is often sustained by adapter
or scaffolding and anchoring proteins [1]. A variety of
binding partners can interact with these organizing
molecules, making it possible to construct intricate
signaling complexes from a simple set of building
blocks. Several recent reviews provide insightful per-
spectives on the roles of signaling complexes main-
tained by these modular adapter proteins in the control
of cellular processes [2–6]. This article will highlight
the added levels of complexity that are conferred by
the compartmentalization of these signaling networks.
Once tethered to distinct sites, kinases and phos-
phatases gain a measure of selectivity in their action
due to their restricted access to a subset of sub-
strates. Subcellular localization provides a means of
spatially segregating broad specificity kinases and
phosphatases to avoid indiscriminate phosphorylation
and dephosphorylation events [7]. 
Organization of MAP Kinase Pathways
Signaling complexes facilitate the processing of
signals that are directed through Mitogen Activated
Protein (MAP) kinase cascades. Each transduction
unit is composed of three sequentially activated protein
kinases: an upstream MAP kinase kinase kinase
(MKKK), an intermediate MAP kinase kinase (MKK)
and a terminal MAP kinase. Scaffolding proteins are
believed to organize each consortium of enzymes to
facilitate and focus the rapid transfer of signals from
one kinase to the next. In the budding yeast Saccha-
romyces cerevisiae, distinct MAP kinase cascades are
assembled from a limited repertoire of enzymes to
control diverse processes such as mating, osmoregu-
latory sensing and pseudohyphal growth [8]. Genetic
and biochemical approaches show that a scaffolding
protein called Sterile 5 (Ste5) organizes the yeast
pheromone response pathway consisting of Sterile 11,
Sterile 7 and the MAP kinases Kss1 or Fus3 [9–11]
(Figure 1). Activation of the terminal kinase causes
specific changes in gene expression and cell cycle
arrest that are a prelude to cell–cell fusion [11]. Recent
data suggest that there are additional levels of regula-
tion within the Ste5 signaling complex, as kinase units
that contain Fus3 selectively phosphorylate the sub-
strate protein Far1 [12]. Furthermore there may be
crosstalk between parallel signaling scaffolds as Ste5-
associated Fus3 seems to attenuate Kss1 kinase
activity in another scaffold [13] (Figure 1).
These sophisticated mechanisms of molecular orga-
nization in yeast MAP kinase cascades highlight the
usefulness of scaffolding proteins for organizing dis-
tinct combinations of enzymes from a pool of common1Correspondence: e-mail: scott@ohsu.edu
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components. For example, Ste11 also functions as the
MKKK in the high osmolarity response pathway where
the MKK Pbs2 acts both as the scaffolding protein and
the intermediate kinase that signals to the downstream
MAP kinase Hog1 [8] (Figure 2). Evidence that the same
enzyme, Ste11, is a component of the pheromone
response and high osmolarity response pathways
shows the importance of kinase scaffolds as a mecha-
nism to confer specificity on the signals relayed through
individual MAP kinase cascades.
In mammalian cells, the JIP family of scaffolding
proteins coordinates activation of the Jun kinase
cascade, whereas a scaffolding protein called MP-1
may increase the efficacy of signaling through the
ERK1/2 pathway [14–17]. Although both proteins
undoubtedly provide platforms for the assembly of
kinase cascades, it is clear that other interactions
between the component kinases further contribute to
the integrity of each complex. Association of MAP
kinase cascade components with scaffolding proteins
may regulate the responsiveness of the cascade to
activating stimuli. Nihalani et al. [18] have shown that
JIP maintains DLK, an upstream kinase in the JNK
pathway, as an inactive, monomeric enzyme. Activa-
tion of this enzyme requires recruitment of the termi-
nal kinase, JNK, into the scaffold. This event releases
DLK from the scaffold to permit its dimerization,
autophosphorylation and activation of the soluble
enzyme within the vicinity of the scaffold [18]. Pre-
sumably, activated DLK is then able to activate MKK7,
the next enzyme in the cascade. This model proposes
that recruitment of the terminal kinase JNK is required
to induce activation of upstream enzymes that are
components of a preassembled and inactive JIP scaf-
fold. Interestingly, other MAP kinase scaffolding pro-
teins, such as KSR, may act in a similar manner as
activated MAPK is recruited into the complex upon
cascade activation [19,20]. 
Signaling through MAP kinase cascades is termi-
nated in part by a growing class of dual specificity
phosphatases whose members dephosphorylate
phosphothreonine and phosphotyrosine residues at
the active site of various component kinases [21].
Initial studies show that protein–protein interaction
with their substrates results in catalytic activation of
certain dual specificity phosphatases [21]. Although it
is not yet clear whether the phosphatases associate
with MAP kinase scaffolding proteins such as JIP,
MP-1 or KSR, the recruitment of phosphatases into
these scaffolds could provide an efficient mechanism
to terminate signaling through each cascade. Pre-
sumably, dephosphorylation of the MAP kinases is
also regulated by conventional serine/threonine and
tyrosine phosphatases [21,22], and it is possible that
certain MAP kinase scaffolds will bind these enzymes
as well.
Figure 1. Pheromone Activation of Yeast
MAP Kinases.
This process involves multiple stages. 
(1) Binding to cell surface GPCRs results
in translocation of the Ste5 kinase scaf-
fold from the nucleus to the plasma mem-
brane. (2) The proximal kinase in the Ste5
kinase scaffold, Ste11, is activated upon
recruitment of Gβγ subunits and another
protein kinase called Ste20. (3) Signals
relayed through the Ste5 kinase scaffold
to the terminal enzyme Fus3 lead to the
phosphorylation of various downstream
substrates. (4) One example is the phos-
phorylation of scaffolds containing Kss3
to attenuate other MAP kinase cascades
that regulate filamentous growth. (5) Phos-
phorylation of another substrate, Far1,
may also contribute to the inhibition of fil-
amentous growth. The name of each
component kinase and scaffolding protein
is shown. 
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Figure 2. MAP Kinase Pathways in Yeast.
Distinct MAP kinase pathways in yeast
have different protein scaffolds. This allows
use of the same component in multiple
pathways. (A) The pheromone response
pathway is composed of the MKKK Ste11,
the MKK Ste7 and the MAP kinase Fus3.
These enzymes form a signaling complex
with the scaffold protein Ste5 at its core.
(B) Pbs2 organizes the hyperosmotic
stress response pathway through its
association with Ste11 and Hog1. The
scaffolding proteins, Ste5 and Pbs2, and
the component kinases are shown. 
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A-Kinase Anchoring Proteins
A-kinase anchoring proteins (AKAPs) are examples of
proteins that compartmentalize signaling complexes
at precise subcellular sites [23]. Members of this
family of functionally related proteins bind to regula-
tory (R) subunit dimers of cAMP-dependent protein
kinase (PKA) holoenzymes through a common amphi-
pathic helix motif of 14–18 residues [23–25]. Unique
targeting domains on each anchoring protein direct
PKA–AKAP complexes to specific subcellular com-
partments, thereby providing a mechanism that posi-
tions PKA to respond to localized changes in cAMP
concentration. Another important function of AKAPs
is to assemble signaling complexes containing multi-
ple kinases, phosphatases and regulatory proteins.
For example, AKAP79 targets PKA, PKC and protein
phosphatase 2B (PP-2B/calcineurin) to neuronal
plasma membranes and synaptic sites [26]. Func-
tional studies have revealed the importance of the
spatial organization of PKA provided by this AKAP
signaling complex. Rosenmund et al. [27] initially
showed that a peptide encompassing the R subunit
binding site in the human thyroid anchoring protein,
Ht31, antagonizes PKA anchoring inside cells. Perfu-
sion of this peptide into cultured hippocampal
neurons causes a rundown of synaptic AMPA type
glutamate receptor activity with a time course that is
similar to the inhibition of the kinase. Further analyses
have shown that the AKAP79 signaling complex is
recruited into a larger transduction unit with its sub-
strate, GluR1, through interaction with a bridging
protein, the membrane associated guanylate kinase
SAP97 [28].
Functional studies show that AKAP79-bound PKA
enhances GluR1 phosphorylation on serine 845 in the
cytoplasmic tail of the receptor. Serine 845 is an impor-
tant site for regulation of channel function during the
induction of long term synaptic depression, and its
phosphorylation state is regulated by PKA in vivo
[29–31]. These data suggest that AKAP79 plays an
important role in the tight coupling of PKA to a sub-
strate, GluR1, and show the importance of compart-
mentalization of a scaffold and its associated proteins
within a restricted subcellular domain. Subsequent
experiments have defined a functional role for other
AKAP signaling complexes and PKA anchoring in a
variety of cAMP dependent events [32,33]. 
Bidirectional Regulation of Signaling by AKAP
Complexes
A valuable feature of some signaling complexes is the
presence of signal transduction and signal termination
enzymes in the same network. This creates focal
points of enzyme activity where the bidirectional reg-
ulation of signaling events can be controlled and the
phosphorylation status of target substrates is pre-
cisely regulated. A common scenario is the clustering
of protein kinase and phosphatase activities. For
example, Yotiao, a splice variant of the AKAP450
gene, binds PKA and protein phosphatase 1 (PP-1).
Yotiao also interacts with the NR1a subunit of synap-
tic NMDA glutamate receptor ion channels, which are
regulated by PKA and PP-1 [34–38] (Figure 3). The
modulation of NMDA receptors containing NR1a
requires interactions with the scaffolding protein as
peptide mediated displacement of either PKA or PP-1
causes changes in the modulation of channel activity
[35]. AKAP450/CG-NAP, a large centrosomal AKAP of
unknown function, has been reported to bind three
kinases, PKA, PKC and PKN, and two phosphatases,
PP-1 and PP-2A [39,40]. Likewise, the simultaneous
association of PP-1 and PKA with anchoring proteins
such as AKAP149/D-AKAP-1 and AKAP 220 undoubt-
edly will contribute to the bidirectional regulation of
phosphorylation events at mitochondria, endoplasmic
reticulum and vesicular organelles [41,42]. Thus, the
possibilities for coordinated phosphorylation and
dephosphorylation events mediated by the enzymes
associated with AKAPs are numerous. 
Two recent reports [43,44] show that phosphodi-
esterases (PDEs), the enzymes that catalyze cAMP
metabolism, are present in signaling complexes 
with the cAMP dependent protein kinase. These find-
ings add a novel twist to PKA regulation as they show
that an anchored pool of phosphodiesterase may
tightly control local cAMP levels. Dodge et al. [43]
found that the muscle selective mAKAP directly binds
PKA and a splice variant of the cAMP-specific, type 4
Figure 3. AKAP Signaling Complexes.
A recently appreciated role for AKAPs is
the simultaneous targeting of signal
transduction and signal termination
enzymes. (A) In neurons, Yotiao maintains
a signaling complex of active phosphatase
PP-1 and PKA that is physically linked to
a substrate for both enzymes, the NR1
subunit of the NMDA receptor ion
channel. (B) In cardiac myocytes, hyper-
trophic stimuli induce expression of 
the muscle selective anchoring protein
mAKAP. This leads to the assembly of a
signaling complex including PKA, the
phosphodiesterase PDE4D3 and the
phosphatase PP-2A that is targeted to a
substrate, the ryanodine receptor ion
channel. 
Current Biology  
Ryanodine receptor
NMDA receptor
Yotiao signaling complex
Sarcoplasmic
recticulumPKA
PP-2A
Csubunit PDE4D3
PKA
A B
mAKAP signaling complex
PP-1
Current Biology
R35
phosphodiesterase, PDE4D3 (Figure 3). Simultane-
ously, Tasken et al. [44] reported the interaction of
PDE4D3 with AKAP450, a large centrosomal AKAP in
testicular Sertoli cells. Biochemical and immunofluo-
rescent analyses show that both enzymes are consti-
tutively associated with the centrosomes during
interphase of the cell cycle [44]. The implications of
both studies are that the role of PDE4D3 within these
complexes is to depress cAMP levels within the vicin-
ity of anchored PKA. At rest, PDE4D3 inhibits basal
PKA activity associated with mAKAP, possibly acting
to dampen noise and increase gain in the system. Fur-
thermore, PKA phosphorylation is known to up-regu-
late PDE4D3 activity 2–3 fold, establishing a negative
feedback loop that rapidly terminates the cAMP signal
[45,46]. It would appear that the close proximity of
PDE4D3 and PKA in the mAKAP signaling complex
facilitates this process as peptide mediated displace-
ment of the kinase from the signaling complex pre-
vents the phosphorylation and up-regulation of the
phosphodiesterase [43].
Although PDE4D3 is a substrate for the kinase, it is
clear that there are other PKA substrates associated
with the mAKAP scaffold (Figure 3). For example, the
regulation of ryanodine receptor (RyR) phosphoryla-
tion is important for maintaining contractility in
response to β-adrenergic signaling and increases 
in intracellular Ca2+ concentration in the heart. Hyper-
phosphorylation of sarcoplasmic reticulum RyR leads
to increased Ca2+ sensitivity of the channel and
decreased sensitivity to β-adrenergic stimulation
[47–49]. These changes are manifest in human heart
tissue undergoing heart failure where changes in 
RyR phosphorylation are also detected [47]. The
abnormal regulation of RyR function may be due to
several factors that regulate cAMP/PKA signaling in
heart, including loss of phosphatase activity from 
the RyR complex [47] and defects in regulation of
cAMP levels by PDE activity associated with the
complex [43] (Figure 3). Thus, the composition and
assembly of this signaling network may be altered in
disease states.
New Roles for Arrestins as Scaffolding Proteins
The β2 adrenergic receptor (β2-AR) is the prototypic
example of a G protein-coupled receptor (GPCR) that
transiently elevates intracellular cAMP through the
stimulation of adenylyl cyclase activity. However, per-
sistent β2-AR activation also leads to receptor desen-
sitization and internalization through a process that
involves phosphorylation of the cytoplasmic tail of the
receptor by G protein-coupled receptor kinases (GRKs)
and the recruitment of arrestins [50]. Although one
function of arrestins is to promote desensitization, it is
now evident that arrestin binding also favors the
assembly of β2-AR signaling complexes and the
nucleation of clathrin cages to mediate endocytosis
[50]. β2-ARs, like many other GPCRs, form higher
order receptor complexes which signal to mammalian
MAP kinase cascades [50]. Lefkowitz and colleagues
([51–53] and references therein) have shown that β2-
AR nucleates an endocytic signaling complex includ-
ing β-arrestin, Src, and EGF receptors that signals to
the ERK1/2 cascade (Figure 4). Internalized protease-
activated receptors are present in a macromolecular
complex that includes β-arrestin 1, Raf-1 and acti-
vated ERKs [54]. Although the molecular mechanisms
that link each receptor to MAP kinase activation are
not precisely defined, the arrestins are key players in
this process.
A further example of arrestin mediated scaffolding
was recently provided by McDonald et al. [55] who
showed that β-arrestin 2 maintains a c-Jun N-terminal
kinase (JNK) kinase module of ASK1, MKK4 and
JNK3. Cell based studies suggested that sequestra-
tion of JNK3 and ASK1 by their simultaneous associ-
ation with β-arrestin 2 enhances activation of JNK3
[55] (Figure 4). Importantly, β-arrestin 2 enhances
JNK3 activity upon application of angiotensin II,
showing that cascade activation is responsive to a
GPCR ligand (Figure 4). This property is reminiscent of
the Sterile 5 complex in yeast where occupancy 
of G protein-coupled pheromone receptors leads 
to the translocation of the entire Ste5-associated 
MAP kinase cascade to the membrane [56,57]. Other
Figure 4. β-Arrestins Function as
Mammalian MAP Kinase Scaffolds.
Accumulating evidence suggests that a
secondary function of β-arrestins may be
to facilitate the assembly of MAP kinase
scaffolds in response to G-protein coupled
receptor-signaling events. (A) Upon acti-
vation of the β2 adrenergic receptor,
β-arrestin 1 and 2 act as scaffolds for the
component kinases of the ERK1/2 MAP
kinase cascade. (B) β-arrestin 2 consti-
tutively binds a JNK kinase module
consisting of ASK1, MKK7 and JNK3 that
is responsive to AT1A angiotensin recep-
tors. The receptor–kinase scaffold is inter-
nalized on clathrin coated vesicles along
with active JNK3. The component kinases
are shown. 
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similarities to yeast MAP kinase scaffolds include the
ability of individual arrestins to interact with distinct
MAP kinase cascades. For example, β-arrestin 1 and
2 recruit members of the ERK cascade upon agonist
stimulation [51,52,55], yet β-arrestin 2 constitutively
associates with members of the JNK cascade [55]
(Figure 4). It will be important to determine if β-arrestin
2 acts as a scaffold for different MAP kinase compo-
nents in a cell-type specific manner, or whether multi-
ple arrestin–MAP kinase modules are segregated
within the same cell. If the latter is the case, what are
the mechanisms that allow coupling of one signal to a
specific arrestin–MAPK module?
GPCR Regulation by AKAP Signaling Complexes
PKA has been implicated in the regulation of GPCR
coupling to multiple G proteins [58,59]. Daaka et al.
[58] showed that β2-ARs normally coupled to cAMP
production through Gαs are also able to activate MAP
kinase pathways in a pertussis toxin-sensitive manner
via a mechanism that involves a switch in coupling
through Gαi/o proteins. They proposed that direct
phosphorylation of β2-AR by PKA enhances coupling
through Gαi leading to activation of ERK1/2. Two
AKAP signaling complexes have been implicated in
the regulation of β2-AR function [60,61] (Figure 5).
AKAP79 binds to regions within the third cytoplasmic
loop and carboxyl terminal tail of the β2-AR in an
agonist-independent manner and peptide disruption
of PKA anchoring attenuates β2-AR mediated ERK
activation in HEK293 cells [61] (Figure 5). AKAP com-
plexes may also coordinate β2-AR phosphorylation,
desensitization and recycling as AKAP250/gravin
recruits PKA and PKC to the receptor in an agonist-
dependent manner [50,60,62] (Figure 5). Anchored
PKA enhances GRK2 mediated receptor phosphoryla-
tion and β2-AR desensitization due to enhanced mem-
brane localization of active GRK2 [63] (Figure 5).
Dephosphorylation of β2-AR and GRK2 are likely to be
important signal termination events in this process.
Interestingly, this function could be mediated by
AKAP79, which also binds to the phosphatase PP-2B.
Implications of Compartmentalization 
One surprising outcome of the human genome project
is that the total number of genes expressed in an indi-
vidual cell is less than was anticipated [64,65]. Yet the
complexity of biological processes requires these
genes to be used in different ways to meet the
demand for cellular diversity. Scaffolding proteins
contribute to this diversity through the assembly of
signaling networks in which enzymes are compart-
mentalized with a subset of their substrates. There are
several implications of this combinatorial model. First,
diversity may be obtained by the selective assembly
of signaling enzymes that associate with a multivalent
anchoring protein. For example AKAP79/150 can
simultaneously interact with PKA, PKC and the phos-
phatase PP-2B, yet theoretically seven distinct signal-
ing complexes could be assembled that contain
various combinations of these signaling enzymes. This
would create a number of slightly different signaling
complexes that could integrate different second mes-
senger signals. Diversity may also be achieved by the
preferential use of targeting signals that are contained
within the anchoring protein. A good example is 
D-AKAP-1/AKAP149 which has distinct targeting
signals within the anchoring protein that differentially
target signaling complexes of PKA and PP-1 to the
endoplasmic reticulum, mitochondria or perinuclear
membranes [42,66]. Diversity in targeting can also be
obtained through alternative splicing of targeting
signals [67]. 
A second postulate is that additional diversity can
be achieved through the dynamic assembly of signal-
ing networks. This can occur on a short time scale via
Figure 5. AKAP Mediated Regulation of
β2-AR Signaling.
Two AKAPs nucleate signaling complexes
that are assembled on β2-ARs. 
(A) Agonist independent association of
the AKAP79 signaling complex through
interactions with sites within the third
intracellular loop and carboxy-terminal
tail of the β2-AR. Phosphorylation of the
third cyto-plasmic loop of the β2-AR (3a)
results in activation of the ERK1/2 kinase
via a Gαi coupled mechanism [58].
Anchored PKA also phosphorylates GRK2
kinase resulting in increased association
of GRK2 with the plasma membrane 
and enhanced receptor phosphorylation 
to stimulate β2-AR desen-sitization. 
(B) Receptor occupancy recruits the
AKAP250/gravin–PKA complex through
interactions with the carboxy-terminal tail
of the β2-AR.
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the organization of existing components into a signal-
ing network as is the case of agonist induced assem-
bly of β2-AR signaling complexes that include
β-arrestin, non-receptor tyrosine kinases and MAP
kinases [52,55]. In addition, de novo synthesis of a
scaffolding protein can provide a developmentally
regulated component to the assembly of signaling
complexes. This has been reported for mAKAP,
expression of which is induced 10–15 fold in car-
diomyocytes upon exposure to agonists that induce
hypertrophy [68]. Increased mAKAP results in the
assembly of a signaling complex that incudes PKA,
PP-2A and the type 4 phosphodiesterase at the perin-
uclear membranes of hypertrophic cardiomyocytes
[43,69]. Fluorescent tracking of proteins in living cells
by techniques such as fluorescence recovery after
photobleaching (FRAP) and fluorescence resonance
energy transfer (FRET) [70] is likely to extend our
appreciation of the dynamics of signaling scaffolds. A
particularly exciting development is the use of green
fluorescent protein (GFP) tagged lipid and protein
interaction domains to track dynamic associations in
real time [71–74]. Likewise, the use of fluorescently
coupled phospho-specific antibodies in situ allows the
resolution of phosphorylation events inside living cells
[75]. These probes allow visual detection of signaling
events and can, in some cases, be used for quantita-
tive calculations of spatial distribution and kinetics of
signaling.
An equally important component of dynamic signal-
ing networks may be the disassembly of these com-
plexes. This could be achieved in two ways:
mislocalization of the signaling scaffold in relation to
its substrates, or targeted degradation of the anchor-
ing or scaffold protein. Both forms of complex disas-
sembly could involve protein ubiquitination pathways.
An E3 ubiquitin ligase is recruited into the IκB–NFκB
transcriptional complex to promote poly-ubiquitination
and degradation of phosphorylated IκB. This process
allows active NF-κB to translocate to the nucleus to
regulate transcription of target genes [76–78]. In
Aplysia sensory neurons, ubiquitination and degrada-
tion of PKA regulatory subunits creates a pool of free,
active catalytic subunit that is important for the induc-
tion of long term synaptic facilitation [79,80]. It would
be interesting to determine whether ubiquitination
alters AKAP signaling complexes in Aplysia. Ubiquiti-
nation has been implicated in the endocytosis and
degradation of pheromone receptors in yeast [81–83]
and EGF receptor complexes in mammalian cells
[84,85]. Shenoy et al. [86] have recently shown that
both β2-AR and β-arrestin are targets for ubiquitina-
tion and that ubiquitination of these proteins con-
tributes to agonist induced receptor trafficking and
degradation. In addition, Marchese and Benovic [87]
have shown that another GPCR, the human immunod-
eficiency virus coreceptor CXCR4 undergoes agonist
induced ubiquitination which promotes receptor
sorting to lysosomes. It is likely that future studies will
identify other signaling networks that are subject to
ubiquitin mediated regulation.
Future Directions
We anticipate that increased use of techniques such
as mass spectrometry, genome-wide two-hybrid
analysis and cell imaging will facilitate the detection
and analysis of signaling complexes. The integration
of these approaches has already led to the development
of protein–protein interaction maps for the yeast
genome [88,89] and no doubt future ventures will
focus on similar analyses of mammalian genomes.
When these data are combined with information
regarding tissue distribution and subcellular localiza-
tion of individual components it should be possible to
develop a more complete picture of the composition
of signaling complexes in individual cells. Genetic
approaches including gene targeting, antisense abla-
tion of gene expression and RNA interference (RNAi)
[90] provide powerful tools to manipulate the expres-
sion and composition of particular signaling networks
in mammalian systems. In addition, highly sophisti-
cated mass spectrometry techniques can be employed
to assess the degree of covalent modification and
possibly the stoichiometry of proteins within signaling
complexes [91]. One persistent limitation to the mass
spectrometry approach is that some of the conditions
used in sample preparation, such as immunoprecipta-
tion or the expression of recombinant epitope tagged
scaffolding proteins, may disrupt or alter the associa-
tion of binding partners with the signaling complex.
Nevertheless, these approaches could be used to
compare the composition and covalent modification
state of certain signaling complexes in normal and
diseased cells. Undoubtedly, these advances will shed
new light on the molecular complexity of cellular sig-
naling processes.
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